Vericiguat inhibits the progress of cardiac hypertrophy and prevents hypertrophy-induced heart failure by multiple mechanisms.

Heart failure (HF) is often a result of cardiac hypertrophy, and it is still the main public health challenge. Although vericiguat has been proved to be effective in treating heart failure through soluble guanylate cyclase (sGC), its potential preven…

Preview only. Read the full abstract at the source